HPR volume 12 issue 14: news (20 April)
Updated 21 December 2018
© Crown copyright 2018
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/health-protection-report-volume-12-2018/hpr-volume-12-issue-14-news-20-april
Multi-drug resistant gonorrhoea in England: an update
Following the first global report of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone in a UK resident [1], two cases of gonorrhoea with resistance to ceftriaxone, azithromycin, ciprofloxacin, penicillin and tetracycline have subsequently been reported in Australia.
In an update to the first report, PHE reminds clinical laboratories to refer all N. gonorrhoeae isolates with resistance to ceftriaxone or azithromycin to the Reference Laboratory in Colindale for confirmation [2]. Related advice is also given for GPs and other health professionals.
References
- PHE (March 2018). UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad.
- PHE (April 2018). Update on investigation of UK case of N. gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad.
Infection reports in this issue of HPR
The following infection reports are published in this issue of HPR. The links below are to the relevant webpage collections or publications.